Clevor

RSS

ropinirole

Authorised
This medicine is authorised for use in the European Union.

Overview

An overview of Clevor and why it is authorised in the EU

Clevor is a veterinary medicine used to induce vomiting in dogs. It contains the active substance ropinirole.

For more information, see the package leaflet.

This EPAR was last updated on 16/05/2018

Authorisation details

Product details
Name
Clevor
Agency product number
EMEA/V/C/004417
Active substance
ropinirole hydrochloride
International non-proprietary name (INN) or common name
ropinirole
Species
Dogs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QN04BC04
Publication details
Marketing-authorisation holder
Orion Corporation
Revision
0
Date of issue of marketing authorisation valid throughout the European Union
12/04/2018
Contact address
Orionintie 1
02 200 Espoo
Finland

Product information

13/04/2018 Clevor - EMEA/V/C/004417 -

Contents

  • Annex I - Summary of product characteristics
  • Annex IIA - Manufacturing-authorisation holder responsible for batch release
  • Annex IIB - Conditions of the marketing authorisation
  • Annex IIIA - Labelling
  • Annex IIIB - Package leaflet

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • DOPAMINERGIC AGENTS
  • Dopamine agonists

Therapeutic indication

Induction of vomiting in dogs.

Assessment history

How useful was this page?

Add your rating